Viewing Study NCT02156895


Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2026-02-24 @ 3:16 PM
Study NCT ID: NCT02156895
Status: COMPLETED
Last Update Posted: 2024-03-08
First Post: 2014-05-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-07-17
Start Date Type: ACTUAL
Primary Completion Date: 2021-04-21
Primary Completion Date Type: ACTUAL
Completion Date: 2021-08-06
Completion Date Type: ACTUAL
First Submit Date: 2014-05-06
First Submit QC Date: None
Study First Post Date: 2014-06-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2022-08-11
Results First Submit QC Date: None
Results First Post Date: 2024-03-08
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-08-11
Last Update Post Date: 2024-03-08
Last Update Post Date Type: ACTUAL